Publications

BibTex format

@article{Gao:2018:10.3390/v10040167,
author = {Gao, Y and McKay, PF and Mann, J},
doi = {10.3390/v10040167},
journal = {Viruses},
title = {Advances in HIV-1 vaccine development},
url = {http://dx.doi.org/10.3390/v10040167},
volume = {10},
year = {2018}
}

Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - An efficacious HIV-1 vaccine is regarded as the best way to halt the ongoing HIV-1 epidemic. However, despite significant efforts to develop a safe and effective vaccine, the modestly protective RV144 trial remains the only efficacy trial to provide some level of protection against HIV-1 acquisition. This review will outline the history of HIV vaccine development, novel technologies being applied to HIV vaccinology and immunogen design, as well as the studies that are ongoing to advance our understanding of vaccine-induced immune correlates of protection.
AU  - Gao,Y
AU  - McKay,PF
AU  - Mann,J
DO  - 10.3390/v10040167
PY  - 2018///
SN  - 1999-4915
TI  - Advances in HIV-1 vaccine development
T2  - Viruses
UR  - http://dx.doi.org/10.3390/v10040167
UR  - http://hdl.handle.net/10044/1/58704
VL  - 10
ER  -

Download

Dr Paul F. McKay

Contact

Location

Summary

Citation

BibTex format

RIS format (EndNote, RefMan)